Arcadia Biosciences (RKDA) Shares Gain on Q1 Earnings Beat

The company reported an adjusted loss of $1.78 per share in the first quarter of 2024, which was narrower than the Zacks Consensus Estimate of a loss of$2.52. This compares to a loss of $3.86 in the year-ago quarter. The company had recorded a valuation loss of$6 million related to March 2023 financing transaction in the first quarter of 2023. Including this, RKDA had reported a loss per share of $10.86 in the first quarter of 2023. Net sales were$1.26 million in the quarter under review, which marked a ...